This article was originally published in The Tan Sheet
The National Institutes of Health awards a $1.6 million Research Project Grant to Luna Innovations to investigate the efficacy of fullerene-based nanomedicines in treating allergies and other inflammatory conditions, according to a July 22 release. Roanoke, Va.-based Luna says it modified fullerenes, a class of carbon molecules, to amplify the immune response in cells and "block the noxious effects of allergies." With the NIH funding, the health science developer intends to further explore systemic, cellular and molecular responses to fullerenes through in vivo and in vitro tests. NIH awarded the grant through its National Institute of General Medical Sciences and participates in the National Nanotechnology Initiative to evaluate nanomaterials (1"The Tan Sheet" Aug. 14, 2006, p. 7)...
Sign in to continue reading.
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: